PMID- 23313465 OWN - NLM STAT- MEDLINE DCOM- 20140422 LR - 20161125 IS - 1874-1754 (Electronic) IS - 0167-5273 (Linking) VI - 167 IP - 5 DP - 2013 Sep 1 TI - 18FDG-positron emission tomography (PET) has a role to play in the diagnosis and therapy of infective endocarditis and cardiac device infection. PG - 1724-36 LID - S0167-5273(12)01633-6 [pii] LID - 10.1016/j.ijcard.2012.12.005 [doi] AB - In recent years, molecular imaging with positron emission tomography (PET) and more recently, PET coupled with computed tomography (CT) have made a valuable impact in various clinical arenas, primarily within the field of oncology, but also in cardiovascular medicine, particularly in detecting coronary artery disease and myocardial viability. More recently, PET imaging has been proven useful in the diagnosis and evaluation of inflammation and infection at different organ sites. Application of PET in the case of Infective Endocarditis (IE) is still in its infancy and indeed the value of this application in the detection of vegetations is debated primarily due to sensitivity issues of the tracer in cardiac tissue and small vegetations. Interestingly, however, reports are now emerging highlighting the role that this application has played in the diagnosis, assessment of complications such as emboli and metastatic infection and the monitoring of therapeutic treatment of IE. More recently, PET/CT has proven valuable in the diagnosis and assessment of cardiac implantable electronic device (CIED)-related infection and its use has highlighted the contribution that this imaging modality may play in assessing the need for surgery in patients with such infections. This article reviews the literature with regard to the potential value of 2-deoxy-2-[(18)F]fluoro-D-glucose ((18)FDG)-PET, as well as the pitfalls and limitations of this imaging modality, in relation to cardiac infection. The emerging role (18)FDG-PET/CT has in the diagnosis and monitoring of IE, particularly prosthetic valve IE and CIED-related infections should be considered, particularly in difficult cases. CI - Copyright (c) 2012 Elsevier Ireland Ltd. All rights reserved. FAU - Millar, B Cherie AU - Millar BC AD - Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AD, Northern Ireland, UK. FAU - Prendergast, Bernard D AU - Prendergast BD FAU - Alavi, Abass AU - Alavi A FAU - Moore, John E AU - Moore JE LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20130111 PL - Netherlands TA - Int J Cardiol JT - International journal of cardiology JID - 8200291 RN - 0Z5B2CJX4D (Fluorodeoxyglucose F18) SB - IM MH - Adult MH - Endocarditis/*diagnostic imaging/etiology MH - Endocarditis, Bacterial/*diagnostic imaging/etiology MH - Female MH - *Fluorodeoxyglucose F18 MH - Humans MH - Male MH - Middle Aged MH - Positron-Emission Tomography/*methods MH - Prosthesis-Related Infections/complications/*diagnostic imaging OTO - NOTNLM OT - Cardiac device OT - Culture-negative OT - Infection OT - Infective endocarditis OT - Pacemaker OT - Positron emission tomography (PET) EDAT- 2013/01/15 06:00 MHDA- 2014/04/23 06:00 CRDT- 2013/01/15 06:00 PHST- 2012/06/27 00:00 [received] PHST- 2012/11/19 00:00 [revised] PHST- 2012/12/01 00:00 [accepted] PHST- 2013/01/15 06:00 [entrez] PHST- 2013/01/15 06:00 [pubmed] PHST- 2014/04/23 06:00 [medline] AID - S0167-5273(12)01633-6 [pii] AID - 10.1016/j.ijcard.2012.12.005 [doi] PST - ppublish SO - Int J Cardiol. 2013 Sep 1;167(5):1724-36. doi: 10.1016/j.ijcard.2012.12.005. Epub 2013 Jan 11.